Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Cubist Pharmaceuticals initiates pivotal clinical trials for daptomycin

March 3, 1999

Pfizer discloses novel macrolide antibiotics

March 3, 1999

Cubist reports new developments in antibiotic program

Feb. 26, 1999

Bayer claims oxazolidinones active against Gram-positive bacteria and mycobacteria

Feb. 26, 1999

New tradename announced for Magainin's pexiganan

Feb. 25, 1999

Advisory committee votes not to recommend approval of Relenza

Feb. 25, 1999

Orally active antifungal agents designed by Janssen scientists

Feb. 24, 1999

New oxazolidinones active against Gram-positive aerobic, anaerobic and other bacteria

Feb. 24, 1999

Licensing opportunity from NIH: mixture of MAbs to treat respiratory infections

Feb. 23, 1999

Roche's new antimalarial compounds active against chloroquine-sensitive and -resistant pathogens

Feb. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...